BGLC vs JKHY · rev $99.0K vs P/E 30, rev $2.54B
BioNexus Gene Lab Corp Common stock (BGLC) versus Jack Henry & Associates Inc (JKHY) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Jack Henry & Associates Inc (JKHY) is a information technology services company listed on US.
Latest reported BGLC revenue for 2026-06-30 was $99.0K. Net income was -$830.0K. BGLC currently screens at market cap $6.1M.
Latest reported JKHY revenue for 2026-06-30 was $2.54B. Net income was $502.8M. Revenue was up 7.1% from 2025-06-30 to 2026-06-30. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
BGLC currently screens at market cap $6.1M. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
Not investment advice. Open the BGLC and JKHY stock pages for the full models.
Not investment advice.